Matches in Wikidata for { <http://www.wikidata.org/entity/Q100528769> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q100528769 description "2020 ވަނަ އަހަރުގެ އޮކްޓޯބަރުމަހުގެ 13ވަނަ ދުވަހު ޝާއިރުކުރެވުނު ލިޔުމެއް" @default.
- Q100528769 description "artículu científicu espublizáu n'ochobre de 2020" @default.
- Q100528769 description "scientific article published on 13 October 2020" @default.
- Q100528769 description "wetenschappelijk artikel" @default.
- Q100528769 description "наукова стаття, опублікована 13 жовтня 2020" @default.
- Q100528769 name "Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells" @default.
- Q100528769 name "Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells" @default.
- Q100528769 name "Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells" @default.
- Q100528769 type Item @default.
- Q100528769 label "Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells" @default.
- Q100528769 label "Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells" @default.
- Q100528769 label "Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells" @default.
- Q100528769 prefLabel "Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells" @default.
- Q100528769 prefLabel "Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells" @default.
- Q100528769 prefLabel "Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells" @default.
- Q100528769 P1433 Q100528769-816F66B3-169A-4BD4-89E0-6DF29C9FDDE0 @default.
- Q100528769 P1476 Q100528769-1CCAACE7-0484-4043-B3A6-D96DD6E50FF6 @default.
- Q100528769 P2093 Q100528769-007097F2-7AFA-4BAA-B324-D26E3DDCBD04 @default.
- Q100528769 P2093 Q100528769-01C45D48-120E-425D-965A-5381ADEF3326 @default.
- Q100528769 P2093 Q100528769-79C84D45-3534-47A6-9EFF-101B29E6109C @default.
- Q100528769 P2093 Q100528769-8C4005CB-04C1-47F4-9DA8-AFAB57706717 @default.
- Q100528769 P2093 Q100528769-9F90D0F0-7AB9-4A0F-9003-80B122C3D399 @default.
- Q100528769 P2093 Q100528769-B4DFD87C-F8C2-4B01-97A8-011EB00983DF @default.
- Q100528769 P2093 Q100528769-BC4163CF-8037-4B92-8842-01CA8BD54F39 @default.
- Q100528769 P2093 Q100528769-BECF8BFE-49B9-45B5-9071-A23B5C2E3F57 @default.
- Q100528769 P2093 Q100528769-C81381AE-1CC2-4031-BABC-30539E3635C7 @default.
- Q100528769 P31 Q100528769-AE0D399B-3D3B-41A8-A9CA-CD070732133E @default.
- Q100528769 P356 Q100528769-31A18888-07C5-48B9-A313-53ACA7F18700 @default.
- Q100528769 P50 Q100528769-7BEF3178-F0C7-40D4-8420-DF3A66756031 @default.
- Q100528769 P577 Q100528769-CA50E1A3-FCA3-4F9F-B593-DD60009F384B @default.
- Q100528769 P698 Q100528769-38633B89-CE2E-447C-BF8B-03F6F448089D @default.
- Q100528769 P356 S10557-020-07083-W @default.
- Q100528769 P698 33048256 @default.
- Q100528769 P1433 Q2473050 @default.
- Q100528769 P1476 "Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells" @default.
- Q100528769 P2093 "Benedikt Preckel" @default.
- Q100528769 P2093 "Coert J Zuurbier" @default.
- Q100528769 P2093 "Gregor Römer" @default.
- Q100528769 P2093 "Jens Kessler" @default.
- Q100528769 P2093 "Jeroen Hermanides" @default.
- Q100528769 P2093 "Laween Uthman" @default.
- Q100528769 P2093 "Marius Kuschma" @default.
- Q100528769 P2093 "Markus W Hollmann" @default.
- Q100528769 P2093 "Marleen Boomsma" @default.
- Q100528769 P31 Q13442814 @default.
- Q100528769 P356 "10.1007/S10557-020-07083-W" @default.
- Q100528769 P50 Q100528768 @default.
- Q100528769 P577 "2020-10-13T00:00:00Z" @default.
- Q100528769 P698 "33048256" @default.